|
🐜
|
Large-scale analysis of the human and mouse transcriptomes
14 auth.
A. Su,
M. Cooke,
K. Ching,
Y. Hakak,
J. Walker,
T. Wiltshire,
A. Orth,
R. Vega,
L. Sapinoso,
A. Moqrich,
...
A. Patapoutian,
G. Hampton,
P. Schultz,
J. Hogenesch
|
10 |
2002 |
10
🐜
|
|
🐜
|
c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability.
7 auth.
O. Vafa,
M. Wade,
S. Kern,
M. Beeche,
T. Pandita,
G. Hampton,
...
G. Wahl
|
9 |
2002 |
9
🐜
|
|
🐢
|
Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer.
8 auth.
J. Welsh,
L. Sapinoso,
Andrew I. Su,
S. Kern,
J. Wang-Rodriguez,
C. Moskaluk,
...
H. Frierson,
G. Hampton
|
9 |
2001 |
9
🐢
|
|
🐢
|
Molecular classification of human carcinomas by use of gene expression signatures.
11 auth.
A. Su,
J. Welsh,
L. Sapinoso,
S. Kern,
P. Dimitrov,
H. Lapp,
...
Peter G Schultz,
S. Powell,
C. Moskaluk,
H. Frierson,
G. Hampton
|
9 |
2001 |
9
🐢
|
|
🐢
|
Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.
9 auth.
J. Welsh,
P. Zarrinkar,
L. Sapinoso,
S. Kern,
C. Behling,
B. Monk,
...
D. Lockhart,
R. Burger,
G. Hampton
|
9 |
2001 |
9
🐢
|
|
🐜
|
Transcriptional regulation and function during the human cell cycle
10 auth.
Raymond J. Cho,
Mingxia Huang,
M. Campbell,
Helin Dong,
L. Steinmetz,
L. Sapinoso,
...
G. Hampton,
S. Elledge,
Ronald W. Davis,
D. Lockhart
|
8 |
2001 |
8
🐜
|
|
🐢
|
Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum
15 auth.
J. Welsh,
L. Sapinoso,
S. Kern,
D. Brown,
Tao Liu,
A. Bauskin,
R. Ward,
N. Hawkins,
D. Quinn,
P. Russell,
...
R. Sutherland,
S. Breit,
C. Moskaluk,
H. Frierson,
G. Hampton
|
8 |
2003 |
8
🐢
|
|
🐬
|
Comprehensive analysis of HE4 expression in normal and malignant human tissues
M. Galgano,
G. Hampton,
H. Frierson
|
8 |
2006 |
8
🐬
|
|
🐜
|
Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non–Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib
11 auth.
E. Punnoose,
S. Atwal,
Weiqun Liu,
R. Raja,
B. Fine,
B. Hughes,
...
R. Hicks,
G. Hampton,
L. Amler,
A. Pirzkall,
M. Lackner
|
8 |
2011 |
8
🐜
|
|
🐬
|
Cdx2 Protein Expression in Normal and Malignant Human Tissues: An Immunohistochemical Survey Using Tissue Microarrays
C. Moskaluk,
Hong Zhang,
S. Powell,
L. Cerilli,
G. Hampton,
H. Frierson
|
8 |
2003 |
8
🐬
|
|
🐜
|
Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant
16 auth.
J. Spoerke,
S. Gendreau,
K. Walter,
J. Qiu,
T. Wilson,
H. Savage,
J. Aimi,
M. Derynck,
Meng Chen,
Iris T. Chan,
...
L. Amler,
G. Hampton,
S. Johnston,
I. Krop,
P. Schmid,
M. Lackner
|
8 |
2016 |
8
🐜
|
|
🐜
|
RhoGDI2 is an invasion and metastasis suppressor gene in human cancer.
9 auth.
J. Gildea,
M. Seraj,
G. Oxford,
Michael A. Harding,
G. Hampton,
C. Moskaluk,
...
H. Frierson,
M. Conaway,
D. Theodorescu
|
7 |
2002 |
7
🐜
|
